Dry Eye Syndrome (DES), also known as dry eye disease or keratoconjunctivitis sicca, is a common condition where the eyes do not produce enough tears or produce poor-quality tears, leading to insufficient lubrication and moisture on the eye's surface. This results in symptoms such as eye dryness, irritation, redness, a gritty sensation, and blurred vision. DES can be caused by various factors, including aging, environmental conditions, certain medications, and underlying health conditions. It can affect daily activities like reading and driving and may lead to more severe eye problems if left untreated.

Dry Eye Syndrome Market Overview

Dry Eye Syndrome Market is expected to reach a CAGR of 7.4% By 2031

Dry Eye Syndrome, also known as Dry Eye Disease, is a common eye condition characterized by insufficient tear production or rapid tear evaporation, leading to discomfort, irritation, and blurred vision. The condition is categorized into two main types: evaporative dry eye and aqueous deficient dry eye.

A variety of products are available to alleviate its symptoms, focusing on lubricating the eyes, improving tear quality, and reducing inflammation. These treatments include artificial tears, eye ointments, anti-inflammatory medications, and cyclosporine eye drops. The market for dry eye syndrome treatments is expected to grow due to the increasing prevalence of the condition, the rising geriatric population, and the broad availability of effective treatment options.

Request for free sample:https://www.datamintelligence.com/download-sample/dry-eye-syndrome-market

Dry Eye Syndrome Market Trends

Increasing Clinical Trials for Dry Eye Syndrome Drugs Expected to Boost Market Growth

The growing number of clinical trials for dry eye syndrome drugs is anticipated to drive market growth. For instance, a clinical study initiated by the Singapore National Eye Centre in April 2022 is exploring the effectiveness of herbal medicine in treating dry eye syndrome in peri/post-menopausal women. This early Phase 1 interventional trial is designed as a randomized, placebo-controlled study, with an estimated completion date of November 2024.

Similarly, Novartis Pharmaceuticals is conducting an observational study in 2023 to investigate various aspects of dry eye disease in patients using lifitegrast ophthalmic solutions in the United Arab Emirates. This prospective cohort study aims to assess clinical characteristics, treatment patterns, real-world effectiveness, and healthcare resource utilization, with an expected completion date of December 30, 2024. These ongoing studies highlight the increasing focus on innovative treatments, contributing to the market's expected growth over the forecast period.

Get your customized report @https://www.datamintelligence.com/customize/dry-eye-syndrome-market

Dry Eye Syndrome Market is segmented

By Type:  Aqueous deficiency, Evaporative

By Product:  Anti-inflammatory Drugs, Lubricant Eye Drops, Punctal Plugs, Oral Omega Supplements, Others

By Dosage Form:  Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments

By Sales Channel:  Prescription, OTC

By Distribution channel:  Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

By Region:  North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Dry Eye Syndrome Market Companies

• Novartis AG
• AbbVie, Inc.
• Sun Pharmaceutical Industries Ltd.
• Santen Pharmaceutical Co., Ltd.
• AFT Pharmaceuticals
• Johnson & Johnson Services, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• OASIS Medical.
• Oyster Point Pharma, Inc.
• Bausch & Lomb

Related Reports

Formulation Development Outsourcing Market

Dental Cement Market

Xerophthalmia Treatment Market  

Contact Us:

Company Name: DataM Intelligence

Email: info@datamintelligence.com

Contact Person: Sai. K

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About DataM Intelligence:

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across